ArticleJournal of clinical pathology2015

Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.

Cédric Poyet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.